Pediatrix Medical Group, Inc.
MD
$17.06
$0.050.29%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -7.03% | -7.42% | 1.19% | 0.90% | 0.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.03% | -7.42% | 1.19% | 0.90% | 0.74% |
| Cost of Revenue | -11.81% | -11.12% | -5.42% | -1.35% | 1.31% |
| Gross Profit | 9.30% | 8.18% | 27.04% | 9.29% | -1.16% |
| SG&A Expenses | -1.50% | -2.65% | 19.77% | 1.25% | -2.50% |
| Depreciation & Amortization | -39.56% | -48.27% | -24.16% | -32.10% | -1.72% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.06% | -10.85% | -2.87% | -1.64% | 0.76% |
| Operating Income | 30.63% | 58.81% | 48.82% | 30.23% | 0.55% |
| Income Before Tax | 132.77% | 259.02% | 124.00% | -18.15% | -530.66% |
| Income Tax Expenses | 206.84% | 94.06% | 119.56% | -38.63% | -237.86% |
| Earnings from Continuing Operations | 125.66% | 413.93% | 124.52% | -9.12% | -641.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 125.66% | 413.93% | 124.52% | -9.12% | -641.07% |
| EBIT | 30.63% | 58.81% | 48.82% | 30.23% | 0.55% |
| EBITDA | 19.91% | 26.98% | 35.07% | 18.63% | 0.19% |
| EPS Basic | 125.21% | 404.31% | 123.80% | -10.58% | -635.05% |
| Normalized Basic EPS | 48.48% | 108.78% | 59.75% | 39.91% | -1.18% |
| EPS Diluted | 125.00% | 392.81% | 123.80% | -11.23% | -641.18% |
| Normalized Diluted EPS | 47.21% | 107.35% | 59.75% | 39.60% | -0.88% |
| Average Basic Shares Outstanding | 1.76% | 1.90% | 3.02% | 1.63% | 1.13% |
| Average Diluted Shares Outstanding | 2.64% | 2.59% | 3.02% | 1.90% | 0.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |